CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Climara +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02256540
NCT02256540N/ACompleted

The Effects of Resveratrol and Acute Exercise on Endothelial Function in Postmenopausal Women

University of Colorado, Denver·interventional·Posted Oct 3, 2014·Updated Mar 20, 2020

In Brief

A clinical study evaluating Climara, Placebo patch, and 2 other interventions for Endothelial Dysfunction. Completed, enrolled 25 participants across 1 site.

Detailed Summary

This pilot study plans to learn more about the aging of blood vessels and arteries in women. As women age and go through menopause, their risk for cardiovascular disease increases. Also with aging and menopause, levels of the reproductive hormone estradiol decline. Hormone replacement therapy to restore estradiol levels does not protect women from cardiovascular disease, so lifestyle changes, such as regular exercise, are recommended to reduce disease risk. However, there are differences between men and women in their response to exercise. In older men, exercise improves the health of their arteries, but in postmenopausal women, exercise does not provide this benefit. The purpose of this pilot study is to determine whether low estradiol levels in postmenopausal women are responsible for the poor vascular response to exercise. In this study the investigators will also test whether treatment with resveratrol, a plant compound found in red wine, improves postmenopausal women's response to exercise. The investigators hypothesize that acute treatment with estrogen or resveratrol will improve vascular responses to an acute bout of exercise.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 3, 2014
Enrollment StartAug 1, 2014
Primary CompletionMar 25, 2016
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 11.7 years ago

Interventions

Climaradrug

Placebo patchdrug

Placebo patch designed to match active Climara patches.

Resveratroldietary

Placebodietary

Placebo tablets designed to match active resveratrol tablets.